Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.

Lipids in health and disease - 15 Jan 2018

Su Xin, Peng Dao-Quan

Abstract excerpt

Dyslipidemia, characterized by elevation of plasma low density lipoprotein cholesterol (LDL-C), triglyceride (TG) and reduction of plasma high density lipoprotein cholesterol (HDL-C), has been verified as a causal risk factor for cardiovascular diseases (CVD), leading to a high mortality rate in general population. It is important to understand the molecular metabolism underlying dyslipidemia in order to reduce...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiopoietin-Like Protein 3
Share to Angiopoietin-like Proteins
Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cholesterol, LDL

Share to Clinical Trials as Topic

Share to Dyslipidemias

Share to Loss of Function Mutation

Share to Triglycerides

Source

Open in PubMed Open full text

Identifiers

PMID: 29334984
DOI: 10.1186/s12944-018-0659-y
PMCID: PMC5769531

Genes

ANGPTL3
LPL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.PMID 29334984Read ↗

ANGPLT3 in cardio-metabolic disorders.Semantic proximity Read ↗

ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases.Semantic proximity Read ↗

Angiopoietin-like 3 in lipoprotein metabolism.Semantic proximity Read ↗

Familial combined hypolipidemia: angiopoietin-like protein-3 deficiencySemantic proximity Read ↗

Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.Semantic proximity Read ↗

How ANGPTL3 Inhibition Will Help Our Clinical Practice?Semantic proximity Read ↗

ANGPTL3 Deficiency and Protection Against Coronary Artery DiseaseSemantic proximity Read ↗

Angptl3 regulates lipid metabolism in mice.Semantic proximity Read ↗

Structures of Angptl3 and Angptl4, modulators of triglyceride levels and coronary artery diseaseSemantic proximity Read ↗

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.Semantic proximity Read ↗

Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3.Semantic proximity Read ↗

Atypical angiopoietin-like protein that regulates ANGPTL3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.